Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 9. Therapeutic progress in multiple sclerosis and neuromyelitis optica].
Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.
Neuroplasticity in Early Onset Multiple Sclerosis.
The Urine Proteome Profile Is Different in Neuromyelitis Optica Compared to Multiple Sclerosis: A Clinical Proteome Study.
Visualization of the medial forebrain bundle using diffusion tensor imaging.
Support our campaign for better treatment for people with MS.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
Is cervical decompression beneficial in patients with coexistent cervical stenosis and multiple sclerosis?
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Quantification of sulfatides and lysosulfatides in tissues and body fluids by liquid chromatography tandem mass spectrometry.
Translating Neurogenomics into New Medicines.
Remodeling myelination: implications for mechanisms of neural plasticity.
Acute recovery from exercise in people with multiple sclerosis: an exploratory study on the effect of exercise intensities.
The multifaceted role of astrocytes in regulating myelination.
White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Congenital and Acquired Abnormalities of the Corpus Callosum: A Pictorial Essay.
Personal identity and the role of 'carer' among relatives and friends of people with multiple sclerosis.
Effect of occupation on risk of developing MS: an insurance cohort study.
Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease.
Baseline Retinal Nerve Fiber Layer Thickness and Macular Volume Quantified by OCT in the North American Phase 3 Fingolimod Trial for Relapsing-Remitting Multiple Sclerosis.
Towards Establishing a Multiple Sclerosis Biobank in Jordan.
Correlation between blink reflex abnormalities and magnetic resonance imaging findings in patients with multiple sclerosis.
Increased Circulating Levels of Vitamin D Binding Protein in MS Patients.
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II).
Pages
« first
‹ previous
…
620
621
622
623
624
625
626
627
628
…
next ›
last »